Matches in SemOpenAlex for { <https://semopenalex.org/work/W1970102311> ?p ?o ?g. }
- W1970102311 endingPage "285" @default.
- W1970102311 startingPage "278" @default.
- W1970102311 abstract "Abstract In B-cell chronic lymphocytic leukemia (B-CLL), malignant cells seem to be arrested in the G0/early G1phase of the cell cycle, and defective apoptosis might be involved in disease progression. However, increasing evidence exists that B-CLL is more than a disease consisting of slowly accumulating resting B cells: a proliferating pool of cells has been described in lymph nodes and bone marrow and might feed the accumulating pool in the blood. Rapamycin has been reported to inhibit cell cycle progression in a variety of cell types, including human B cells, and has shown activity against a broad range of human tumor cell lines. Therefore, we investigated the ability of rapamycin to block cell cycle progression in proliferating B-CLL cells. We have recently demonstrated that stimulation with CpG-oligonucleotides and interleukin-2 provides a valuable model for studying cell cycle regulation in malignant B cells. In our present study, we demonstrated that rapamycin induced cell cycle arrest in proliferating B-CLL cells and inhibited phosphorylation of p70s6 kinase (p70s6k). In contrast to previous reports on nonmalignant B cells, the expression of the cell cycle inhibitor p27 was not changed in rapamycin-treated leukemic cells. Treatment with rapamycin prevented retinoblastoma protein (RB) phosphorylation in B-CLL cells without affecting the expression of cyclin D2, but cyclin D3 was no longer detectable in rapamycin-treated B-CLL cells. In addition, rapamycin treatment inhibited cyclin-dependent kinase 2 activity by preventing up-regulation of cyclin E and cyclin A. Interestingly, survivin, which is expressed in the proliferation centers of B-CLL patients in vivo, is not up-regulated in rapamycin-treated cells. Therefore, rapamycin interferes with the expression of many critical molecules for cell cycle regulation in cycling B-CLL cells. We conclude from our study that rapamycin might be an attractive substance for therapy for B-CLL patients by inducing a G1 arrest in proliferating tumor cells." @default.
- W1970102311 created "2016-06-24" @default.
- W1970102311 creator A5005474411 @default.
- W1970102311 creator A5022268863 @default.
- W1970102311 creator A5026988190 @default.
- W1970102311 creator A5029656956 @default.
- W1970102311 creator A5039868942 @default.
- W1970102311 creator A5062661095 @default.
- W1970102311 creator A5066200247 @default.
- W1970102311 date "2003-01-01" @default.
- W1970102311 modified "2023-10-11" @default.
- W1970102311 title "Rapamycin-induced G1 arrest in cycling B-CLL cells is associated with reduced expression of cyclin D3, cyclin E, cyclin A, and survivin" @default.
- W1970102311 cites W1486193010 @default.
- W1970102311 cites W1537129572 @default.
- W1970102311 cites W1568808961 @default.
- W1970102311 cites W1662899239 @default.
- W1970102311 cites W1927722917 @default.
- W1970102311 cites W1956007715 @default.
- W1970102311 cites W1963723155 @default.
- W1970102311 cites W1968655578 @default.
- W1970102311 cites W1969617808 @default.
- W1970102311 cites W1971487921 @default.
- W1970102311 cites W1980720313 @default.
- W1970102311 cites W1982398354 @default.
- W1970102311 cites W1984545745 @default.
- W1970102311 cites W1986264978 @default.
- W1970102311 cites W1987105275 @default.
- W1970102311 cites W1988609792 @default.
- W1970102311 cites W1993730263 @default.
- W1970102311 cites W2010336249 @default.
- W1970102311 cites W2011010559 @default.
- W1970102311 cites W2011485783 @default.
- W1970102311 cites W2015277956 @default.
- W1970102311 cites W2019963645 @default.
- W1970102311 cites W2021668967 @default.
- W1970102311 cites W2022736043 @default.
- W1970102311 cites W2022978203 @default.
- W1970102311 cites W2026351725 @default.
- W1970102311 cites W2026389696 @default.
- W1970102311 cites W2029080338 @default.
- W1970102311 cites W2030019992 @default.
- W1970102311 cites W2033989981 @default.
- W1970102311 cites W2035523654 @default.
- W1970102311 cites W2052741482 @default.
- W1970102311 cites W2057479779 @default.
- W1970102311 cites W2059333451 @default.
- W1970102311 cites W2078161165 @default.
- W1970102311 cites W2079187701 @default.
- W1970102311 cites W2086899319 @default.
- W1970102311 cites W2102648794 @default.
- W1970102311 cites W2116382475 @default.
- W1970102311 cites W2119874496 @default.
- W1970102311 cites W2121203285 @default.
- W1970102311 cites W2125861971 @default.
- W1970102311 cites W2139573199 @default.
- W1970102311 cites W2148724358 @default.
- W1970102311 cites W2160079255 @default.
- W1970102311 cites W2168851383 @default.
- W1970102311 cites W2171319865 @default.
- W1970102311 cites W2172159375 @default.
- W1970102311 cites W2221262359 @default.
- W1970102311 cites W2268103037 @default.
- W1970102311 cites W2415890524 @default.
- W1970102311 cites W2417341920 @default.
- W1970102311 cites W2417543242 @default.
- W1970102311 cites W4251555887 @default.
- W1970102311 cites W4254357547 @default.
- W1970102311 cites W51210568 @default.
- W1970102311 doi "https://doi.org/10.1182/blood-2002-01-0189" @default.
- W1970102311 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12393642" @default.
- W1970102311 hasPublicationYear "2003" @default.
- W1970102311 type Work @default.
- W1970102311 sameAs 1970102311 @default.
- W1970102311 citedByCount "158" @default.
- W1970102311 countsByYear W19701023112012 @default.
- W1970102311 countsByYear W19701023112013 @default.
- W1970102311 countsByYear W19701023112014 @default.
- W1970102311 countsByYear W19701023112015 @default.
- W1970102311 countsByYear W19701023112016 @default.
- W1970102311 countsByYear W19701023112017 @default.
- W1970102311 countsByYear W19701023112018 @default.
- W1970102311 countsByYear W19701023112019 @default.
- W1970102311 countsByYear W19701023112020 @default.
- W1970102311 countsByYear W19701023112021 @default.
- W1970102311 countsByYear W19701023112022 @default.
- W1970102311 countsByYear W19701023112023 @default.
- W1970102311 crossrefType "journal-article" @default.
- W1970102311 hasAuthorship W1970102311A5005474411 @default.
- W1970102311 hasAuthorship W1970102311A5022268863 @default.
- W1970102311 hasAuthorship W1970102311A5026988190 @default.
- W1970102311 hasAuthorship W1970102311A5029656956 @default.
- W1970102311 hasAuthorship W1970102311A5039868942 @default.
- W1970102311 hasAuthorship W1970102311A5062661095 @default.
- W1970102311 hasAuthorship W1970102311A5066200247 @default.
- W1970102311 hasBestOaLocation W19701023111 @default.
- W1970102311 hasConcept C11882975 @default.
- W1970102311 hasConcept C120089663 @default.
- W1970102311 hasConcept C120504264 @default.